Decreased expression of CTTN leads to arrhythmias in mice [58], so it may inhibit the potassium ion channel Kv1.5 in LQT7 patients for prolonging the APD and QT intervals to aggravate the clinical symptoms. This evidence concerns the gene CTTN and Arrhythmia.